Database : MEDLINE
Search on : pleurisy [Words]
References found : 6173 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 618 go to page                         

  1 / 6173 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 29515733
[Au] Autor:El Hachimi K; Benjelloun H; Zaghba N; Yassine N
[Ad] Address:Service des Maladies Respiratoires, CHU Ibn Rochd, Casablanca, Maroc.
[Ti] Title:Métastase pleurale et pulmonaire d'une polyadénofibromatose dégénéréé: à propos d'un cas. [Pleural and lung metastasis from degenerated multiple adenofibromas: about a case].
[So] Source:Pan Afr Med J;28:115, 2017.
[Is] ISSN:1937-8688
[Cp] Country of publication:Uganda
[La] Language:fre
[Ab] Abstract:Multiple adenofibromas or adenofibromatosis is characterized by the presence of at least 3 mono- or bilateral adenofibromas increasing significantly in size, causing trophic disorders. We report the case of a 46-year old female patient who had been followed up since she was 30 years old for bilateral adenofibromatosis that required 4 surgical procedures. Patient's medical data were collected in the Department of Respiratory Diseases at the Ibn Rochd University Hospital Center, Casablanca. Basing on preoperative assessment before bilateral mastectomy, the patient underwent chest X-ray that showed opaque right hemithorax exerting compression on the mediastinum. Clinical examination showed effusion syndrome in the right hemithorax and left supraclavicular cervical adenopathy. Pleural puncture biopsy confirmed the presence of poorly differentiated invasive carcinoma in the pleura, supporting breast origin. Bronchoscopy after pleural puncture objectified infiltration of the whole bronchial tree; biopsies confirmed the anatomopathological results. The recommended treatment strategy was based on multidrug chemotherapy. Patient's evolution was marked by the occurrence of hepatic metastases. This study shows that adenofibromas require regular monitoring given the risk of trasformation to breast cancer, which is a frequent cause of pleuropulmonary metastases.
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180311
[Lr] Last revision date:180311
[St] Status:In-Process
[do] DOI:10.11604/pamj.2017.28.115.13599

  2 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29515723
[Au] Autor:El Euch M; Haddad S; Mahfoudhi M; Hamida FB; Jaziri F; Abdelghani KB; Turki S; Abdallah TB
[Ad] Address:Service de Médecine Interne « A ¼ Hôpital Charles Nicolle, Tunis, Tunisie.
[Ti] Title:Maladie cÅ“liaque de l'adulte révélée par une polysérite. [Celiac disease in adult patients revealed by polyserositis: about a case].
[So] Source:Pan Afr Med J;28:105, 2017.
[Is] ISSN:1937-8688
[Cp] Country of publication:Uganda
[La] Language:fre
[Ab] Abstract:Celiac disease (CD) is an autoimmune disease affecting multiple organs. It often presents as gastrointestinal manifestations associated with malabsorption. However, serosa involvement uncommonly reveals this enteropathy, making the diagnosis difficult. We here report the case of JA, aged 63 years, admitted to hospital to detect the cause of malabsorption syndrome associated with polyserositis signs including pleurisy, pericarditis, ascites and hydrocephalus. The diagnosis of CD was based on endoscopic signs without serology tests. Patient's evolution was partially favorable, due to lack of compliance with a gluten-free diet. Our study reports the first case of CD revealed by polyserositis. CD should be suspected in patients with malabsorption syndrome, in the absence of evocative signs.
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180311
[Lr] Last revision date:180311
[St] Status:In-Process
[do] DOI:10.11604/pamj.2017.28.105.10878

  3 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29499192
[Au] Autor:Sandes SMS; Heimfarth L; Brito RG; Santos PL; Gouveia DN; Carvalho AMS; Quintans JSS; da Silva-Júnior EF; de Aquino TM; França PHB; de Araújo-Júnior JX; Albuquerque-Júnior RLC; Zengin G; Schmitt M; Bourguignon JJ; Quintans-Júnior LJ
[Ad] Address:Laboratory of Neuroscience and Pharmacological Assay (LANEF), Graduate Program in Health Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
[Ti] Title:Evidence for the involvement of TNF-α, IL-1ß and IL-10 in the antinociceptive and anti-inflammatory effects of indole-3-guanylhydrazone hydrochloride, an aromatic aminoguanidine, in rodents.
[So] Source:Chem Biol Interact;286:1-10, 2018 Feb 27.
[Is] ISSN:1872-7786
[Cp] Country of publication:Ireland
[La] Language:eng
[Ab] Abstract:BACKGROUND: Indole-3-guanylhydrazone hydrochloride (LQM01) is a new derivative of aminoguanidine hydrochloride, an aromatic aminoguanidine. METHODS: Mice were treated with LQM01 (5, 10, 25 or 50 mg/kg, i.p.), vehicle (0.9% saline i.p.) or a standard drug. The mice were subjected to carrageenan-induced pleurisy, abdominal writhing induced by acetic acid, the formalin test and the hot-plate test. The model of non-inflammatory chronic muscle pain induced by saline acid was also used. Mice from the chronic protocol were assessed for withdrawal threshold, muscle strength and motor coordination. LQM01 or vehicle treated mice were evaluated for Fos protein. RESULTS: LQM01 inhibits TNF-α and IL-1ß production, as well as leukocyte recruitment during inflammation process. The level of IL-10 in LQM01-treated mice increased in pleural fluid. In addition, LQM01 decreased the nociceptive behavior in the acetic acid induced writhing test, the formalin test (both phases) and increased latency time on the hot-plate. LQM01 treatment also decreased mechanical hyperalgesia in mice with chronic muscle pain, with no changes in muscle strength and motor coordination. LQM01 reduced the number of Fos positive cells in the superficial dorsal horn. This compound exhibited antioxidant properties in in vitro assays. CONCLUSIONS: LQM01 has an outstanding anti-inflammatory and analgesic profile, probably mediated through a reduction in proinflammatory cytokines release, increase in IL-10 production and reduction in neuron activity in the dorsal horn of the spinal cord in mice. GENERAL SIGNIFICANCE: Beneficial effects of LQM01 suggest that it has some important clinical features and can play a role in the management of 'dysfunctional pain' and inflammatory diseases.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180310
[Lr] Last revision date:180310
[St] Status:Publisher

  4 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29243291
[Au] Autor:Ekuadzi E; Biney RP; Benneh CK; Osei Amankwaa B; Jato J
[Ad] Address:Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
[Ti] Title:Antiinflammatory properties of betulinic acid and xylopic acid in the carrageenan-induced pleurisy model of lung inflammation in mice.
[So] Source:Phytother Res;32(3):480-487, 2018 Mar.
[Is] ISSN:1099-1573
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:This study investigated the antiinflammatory properties of betulinic acid (BA) and xylopic acid (XA) extracted from Margaritaria discoidea and Xylopia aethiopica, respectively. M. discoidea and X. aethiopica are plants native in Ghana and the West-African region and used traditionally to treat different pathologies including inflammatory conditions. The antiinflammatory effect of BA and XA was established by an in vivo assay using the carrageenan-induced pleural inflammation model in mice. Also, the ability of BA and XA to increase catalase, superoxide dismutase, glutathione levels and decrease lipid peroxidation level in reactive oxidative assays was assessed. In addition, the ability of XA and BA to prevent potential lung tissue damage was quantified. Pretreatment with BA and XA reduced significantly, signs of inflammation: neutrophil infiltration, oedema, and alveoli septal thickening in carrageenan-treated lung tissue. Additionally, BA or XA pretreatment lowered the degree of lipid peroxidation in the lung tissue while increasing the levels of catalase, superoxide dismutase, and glutathione in vivo. Comparatively, XA was more efficacious than BA in the prevention of lung tissue damage. BA and XA derived from X. aethiopica and M. discoidea possess antiinflammatory and in vivo antioxidant activities in mice pleurisy model. The effect of these compounds gives credence to the traditional use in the management of inflammatory conditions of the airway.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1712
[Cu] Class update date: 180306
[Lr] Last revision date:180306
[St] Status:In-Process
[do] DOI:10.1002/ptr.5993

  5 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29504148
[Au] Autor:Zhang X; Sun Y; He C; Qiu X; Zhou D; Ye Z; Long Y; Tang T; Su X; Ma J
[Ad] Address:Sun Yat-sen University Cancer Center, Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
[Ti] Title:The immune characterization of IFN-ß responses in tuberculosis patients.
[So] Source:Microbiol Immunol;, 2018 Mar 05.
[Is] ISSN:1348-0421
[Cp] Country of publication:Australia
[La] Language:eng
[Ab] Abstract:We aimed to assess the immunoregulatory effects of IFN-ß in patients with tuberculous pleurisy. IFN-ß, IFN-γ and IL-17 expression levels were detected, and correlations among these factors in different culture groups were analyzed. Pleural fluid mononuclear cells (PFMCs) from tuberculous pleural effusions, but not peripheral blood mononuclear cells (PBMCs) from healthy donors, spontaneously expressed IFN-ß, IL-17 and IFN-γ. Moreover, exogenous IFN-ß significantly inhibited the expression of IL-17 in PFMCs. By contrast, IFN-ß simultaneously enhanced the levels of IFN-γ. To further investigate the regulation of IL-17 and IFN-γ by endogenous IFN-ß, an IFN-ß neutralizing antibody was simultaneously added to BCG-stimulated PFMCs. IL-17 expression was significantly increased, but IFN-γ production was markedly decreased in the experimental group supplemented with the IFN-ß neutralizing antibody. Simultaneously, IL-17 production was remarkably increased in the experimental group supplemented with the IFN-γ neutralizing antibody. Taken together, in our study, we first found that freshly isolated PFMCs, but not PBMCs from healthy donors, spontaneously expressed IFN-ß, IL-17 and IFN-γ in vivo. Moreover, IFN-ß suppressed IL-17 expression and increased IFN-γ production. Furthermore, both IFN-ß and IFN-γ downregulated IL-17 expression. These observations suggest that caution is required when basing anti-TB treatment on the inhibition of IFN-ß signaling.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180305
[Lr] Last revision date:180305
[St] Status:Publisher
[do] DOI:10.1111/1348-0421.12583

  6 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29390341
[Au] Autor:Li M; Zhu W; Khan RSU; Saeed U; Wang R; Shi S; Luo Z
[Ad] Address:Department of Respiratory Medicine.
[Ti] Title:Accuracy of interleukin-27 assay for the diagnosis of tuberculous pleurisy: A PRISMA-compliant meta-analysis.
[So] Source:Medicine (Baltimore);96(50):e9205, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: The concentration of interleukin-27 (IL-27) in pleural effusions was found to be increased in tuberculous pleurisy and several studies have investigated the diagnostic value of IL-27 for tuberculous pleural effusions (TPEs), but the results varied a lot. We conducted the present study to comprehensively evaluate the diagnostic value of IL-27 for TPE. METHODS: Primary diagnostic test studies of IL-27 for TPE was searched and identified from databases. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ration, diagnostic odds ratio, and receiver operating characteristic curves (SROCs) were computed or pooled to summarize the overall test performance. RESULTS: Nine studies with a total number of 1226 patients were identified in our research. The main pooled estimates were as follows: sensitivity 0.92 [95% confidence interval (CI), 0.90-0.95], specificity 0.90 (95% CI, 088-0.92), and area under the SROC 0.97. No evidence of publication bias was detected. CONCLUSION: Our research suggested the good diagnostic value of IL-27 for TPE and it could be used as a diagnostic biomarker.
[Mh] MeSH terms primary: Interleukin-27/analysis
Pleural Effusion/diagnosis
Tuberculosis, Pleural/diagnosis
[Mh] MeSH terms secundary: Biomarkers/analysis
Humans
Sensitivity and Specificity
[Pt] Publication type:JOURNAL ARTICLE; META-ANALYSIS
[Nm] Name of substance:0 (Biomarkers); 0 (Interleukin-27)
[Em] Entry month:1802
[Cu] Class update date: 180301
[Lr] Last revision date:180301
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009205

  7 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29381918
[Au] Autor:Xu HY; Li CY; Su SS; Yang L; Ye M; Ye JR; Ke PP; Chen CS; Xie YP; Li YP
[Ad] Address:Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, PR China.
[Ti] Title:Diagnosis of tuberculous pleurisy with combination of adenosine deaminase and interferon-γ immunospot assay in a tuberculosis-endemic population: A prospective cohort study.
[So] Source:Medicine (Baltimore);96(47):e8412, 2017 Nov.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:The aim of this study was to identify the optimal cut-off value of T cell enzyme-linked immunospot assay for tuberculosis (T-SPOT.TB) and evaluate its diagnostic performance alone (in the peripheral blood) or in combination with the adenosine deaminase (ADA) activity test (in peripheral blood and the pleural fluid) in patients with tuberculous pleurisy.Adult patients presenting with pleural effusion were included in this prospective cohort study. Tuberculous pleurisy was diagnosed by T-SPOT.TB in peripheral blood and a combination of T-SPOT.TB and ADA activity test in pleural fluid and peripheral blood. Receiver operating characteristic (ROC) curve in combination with multivariate logistic regression was used to evaluate the diagnostic performance of the assays.Among a total of 189 patients with suspected tuberculous pleurisy who were prospectively enrolled in this study, 177 patients were validated for inclusion in the final analysis. ROC analysis revealed that the area under the ROC curve (AUC) for T-SPOT.TB in pleural fluid and peripheral blood was 0.918 and 0.881, respectively, and for the ADA activity test in pleural fluid was 0.944. In addition, 95.5 spot-forming cells (SFCs)/2.5 × 10 cells were determined as the optimal cut-off value for T-SPOT.TB in pleural fluid. Parallel combination of T-SPOT.TB and ADA activity test in pleural fluid showed increased sensitivity (96.9%) and specificity (87.5%), whereas serial combination showed increased specificity (97.5%). The combination of 3 assays had the highest sensitivity at 97.9%, with an AUC value of 0.964.T-SPOT.TB in pleural fluid performed better than that in peripheral blood and the ADA activity test in pleural fluid for tuberculous pleurisy diagnosis. The optimal cut-off value of T-SPOT.TB in pleural fluid was 95.5 SFCs/2.5 × 10 cells. Combination of 3 assays might be a promising approach for tuberculous pleurisy diagnosis.
[Mh] MeSH terms primary: Adenosine Deaminase/immunology
Enzyme-Linked Immunospot Assay/methods
Interferon-gamma/immunology
Tuberculosis, Pleural/diagnosis
Tuberculosis, Pleural/immunology
[Mh] MeSH terms secundary: Adult
Aged
Enzyme-Linked Immunospot Assay/standards
Female
Hematologic Tests
Humans
Male
Middle Aged
Pleural Effusion/immunology
Prospective Studies
ROC Curve
Reference Values
Sensitivity and Specificity
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:82115-62-6 (Interferon-gamma); EC 3.5.4.4 (Adenosine Deaminase)
[Em] Entry month:1802
[Cu] Class update date: 180220
[Lr] Last revision date:180220
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180201
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000008412

  8 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29446176
[Au] Autor:Li R; Weintraub E; McNeil MM; Kulldorff M; Lewis EM; Nelson J; Xu S; Qian L; Klein NP; Destefano F
[Ad] Address:Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, USA.
[Ti] Title:Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method.
[So] Source:Pharmacoepidemiol Drug Saf;, 2018 Feb 15.
[Is] ISSN:1099-1557
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:PURPOSE: The objective of our study was to conduct a data mining analysis to identify potential adverse events (AEs) following MENACWY-D using the tree-temporal scan statistic in the Vaccine Safety Datalink population and demonstrate the feasibility of this method in a large distributed safety data setting. METHODS: Traditional pharmacovigilance techniques used in vaccine safety are generally geared to detecting AEs based on pre-defined sets of conditions or diagnoses. Using a newly developed tree-temporal scan statistic data mining method, we performed a pilot study to evaluate the safety profile of the meningococcal conjugate vaccine Menactra® (MenACWY-D), screening thousands of potential AE diagnoses and diagnosis groupings. The study cohort included enrolled participants in the Vaccine Safety Datalink aged 11 to 18 years who had received MenACWY-D vaccination(s) between 2005 and 2014. The tree-temporal scan statistic was employed to identify statistical associations (signals) of AEs following MENACWY-D at a 0.05 level of significance, adjusted for multiple testing. RESULTS: We detected signals for 2 groups of outcomes: diseases of the skin and subcutaneous tissue, fever, and urticaria. Both groups are known AEs following MENACWY-D vaccination. We also identified a statistical signal for pleurisy, but further examination suggested it was likely a false signal. No new MENACWY-D safety concerns were raised. CONCLUSIONS: As a pilot study, we demonstrated that the tree-temporal scan statistic data mining method can be successfully applied to screen broadly for a wide range of vaccine-AE associations within a large health care data network.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180215
[Lr] Last revision date:180215
[St] Status:Publisher
[do] DOI:10.1002/pds.4397

  9 / 6173 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29437801
[Au] Autor:Yamoto M; Kawagishi Y; Murata A; Tsuji H
[Ad] Address:Respiratory Medicine, Kurobe City Hospital, Kurobe, Japan.
[Ti] Title:Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapy.
[So] Source:BMJ Case Rep;2018, 2018 Feb 08.
[Is] ISSN:1757-790X
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:We report two cases of pleurisy caused by non-tuberculous mycobacteria followed by pneumothorax. The onset of pleurisy was accompanied by acute fever. Cultured samples of the pleural effusions from the two patients, an 80-year-old man and an 87-year-old woman, were ultimately found to contain and , respectively. Both patients were initially administered antibiotics, but their fevers persisted. Therefore, different combinations of antimycobacterial drugs were used, which reduced the fever in a few days. In these patients, pleurisy caused by non-tuberculous mycobacteria followed by pneumothorax was characterised by acute fever and improvement in the fever after administration of antimycobacterial drugs; however, the aetiology remains to be clarified.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180213
[Lr] Last revision date:180213
[St] Status:In-Process

  10 / 6173 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 29434155
[Au] Autor:Hase I; Kurasawa K; Takizawa H; Yamaguchi B; Sakuma H; Ishii Y
[Ad] Address:Department of Respiratory Disease, Southern Tohoku General Hospital, Japan.
[Ti] Title:Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome.
[So] Source:Intern Med;, 2018 Feb 09.
[Is] ISSN:1349-7235
[Cp] Country of publication:Japan
[La] Language:eng
[Ab] Abstract:Yellow nail syndrome (YNS) pleurisy is often difficult to control, and pathological examinations have rarely been reported. We herein report a case of bucillamine-induced YNS in which histopathology of the parietal pleura revealed hyperplasia of the lymphoid follicles and lymphangiectasia. Even after the discontinuation of bucillamine, the pleurisy and lymphedema showed no change. Based on the histopathological findings showing similarity to rheumatoid pleurisy, we administered corticosteroid treatments, and both the pleurisy and lymphedema improved. The findings in the present case suggest that, in bucillamine-induced YNS, pleurisy may be related to inflammation caused by rheumatoid arthritis in addition to abnormalities in lymphatic vessels.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180213
[Lr] Last revision date:180213
[St] Status:Publisher
[do] DOI:10.2169/internalmedicine.9679-17


page 1 of 618 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information